
Brainsway (BWAY) Stock Forecast & Price Target
Brainsway (BWAY) Analyst Ratings
Bulls say
BrainsWay Ltd is experiencing a favorable advancement in its business operations, evidenced by a greater than 50% increase in equipment utilization rates since the establishment of key investments. The company is also positioning itself for accelerated revenue growth through additional strategic investments, which are expected to enhance its financial performance. Furthermore, the initial equity financing transaction has established a positive framework, reinforcing confidence in the company's growth trajectory and potential for future profitability.
Bears say
BrainsWay Ltd faces several fundamental risks that contribute to a negative outlook on its stock. Key concerns include the slower-than-expected adoption of its Deep TMS systems, difficulties in expanding reimbursement and market access, and challenges in advancing clinical indications beyond current offerings. Additionally, the potential for long-term dilution poses a risk to shareholders, impacting the company's financial stability and growth prospects.
This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.
Brainsway (BWAY) Analyst Forecast & Price Prediction
Start investing in Brainsway (BWAY)
Order type
Buy in
Order amount
Est. shares
0 shares